BR9103506A - Novos usos de l-deprenil e composicoes para ele - Google Patents

Novos usos de l-deprenil e composicoes para ele

Info

Publication number
BR9103506A
BR9103506A BR919103506A BR9103506A BR9103506A BR 9103506 A BR9103506 A BR 9103506A BR 919103506 A BR919103506 A BR 919103506A BR 9103506 A BR9103506 A BR 9103506A BR 9103506 A BR9103506 A BR 9103506A
Authority
BR
Brazil
Prior art keywords
deprenil
compositions
new uses
deprenyl
frequence
Prior art date
Application number
BR919103506A
Other languages
English (en)
Portuguese (pt)
Inventor
Norton W Milgram
David R Stevens
Gwendolyn O Ivy
Original Assignee
Deprenyl Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27076843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9103506(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/576,011 external-priority patent/US5151449A/en
Application filed by Deprenyl Animal Health Inc filed Critical Deprenyl Animal Health Inc
Publication of BR9103506A publication Critical patent/BR9103506A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thin Film Transistor (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Insulating Materials (AREA)
  • Pulse Circuits (AREA)
BR919103506A 1990-08-31 1991-08-15 Novos usos de l-deprenil e composicoes para ele BR9103506A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/576,011 US5151449A (en) 1990-08-31 1990-08-31 Use of L-deprenyl for retention of specific physiological functions
US64345291A 1991-01-18 1991-01-18

Publications (1)

Publication Number Publication Date
BR9103506A true BR9103506A (pt) 1992-05-12

Family

ID=27076843

Family Applications (1)

Application Number Title Priority Date Filing Date
BR919103506A BR9103506A (pt) 1990-08-31 1991-08-15 Novos usos de l-deprenil e composicoes para ele

Country Status (15)

Country Link
US (2) US5276057A (en11)
EP (2) EP0473252B1 (en11)
JP (3) JP2819072B2 (en11)
AT (2) ATE181501T1 (en11)
AU (1) AU633714B2 (en11)
BR (1) BR9103506A (en11)
CA (1) CA2039194C (en11)
DE (2) DE69124875T2 (en11)
DK (2) DK0473252T3 (en11)
ES (2) ES2135123T3 (en11)
GR (2) GR3022971T3 (en11)
ID (1) ID19492A (en11)
MX (1) MX9100067A (en11)
MY (2) MY124210A (en11)
NZ (1) NZ238277A (en11)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561163A (en) * 1990-08-31 1996-10-01 Deprenyl Animal Health, Inc. Treating hearing loss with deprenyl
US5565495A (en) * 1990-08-31 1996-10-15 Deprenyl Animal Health, Inc. Method for survival curve shifting in dogs
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
EP0578687A1 (en) * 1991-04-04 1994-01-19 The University Of Toronto Innovations Foundation Use of deprenyl to maintain, prevent loss, or recover nerve cell function
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
US5547995B1 (en) * 1993-05-04 1998-01-27 Sanofi Elf Use of selegiline in veterinary medicine
HU223475B1 (hu) * 1994-10-24 2004-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
JP3036847B2 (ja) 1995-01-13 2000-04-24 サマーセット・ファーマシューティカルズ・インコーポレイテッド デスメチルセレギリンを用いる方法および医薬組成物
JPH10513455A (ja) 1995-02-10 1998-12-22 ザ ユニバーシティ オブ トロント イノベーションズ ファウンデーション 緑内障治療用のデプレニル化合物
CA2223588C (en) * 1995-06-07 2004-01-06 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
CA2236368C (en) * 1995-11-06 2001-10-23 Somerset Pharmaceuticals, Inc. Sublingual and buccal administration of selegiline
BR9908713A (pt) * 1998-03-16 2000-11-21 Somerset Pharmaceuticals Inc Uso de selegilina ou desmetil-selegilina para tratamento de feridas, queimaduras e danos dermatológicos
US20030212144A1 (en) * 2001-07-18 2003-11-13 Mohankumar Sheba J.J. Method for inducing an estrous cycle and pregnancy in a female mammal
EP1565185A4 (en) * 2002-11-07 2011-01-05 Technion Res & Dev Foundation NEUROPROTECTIVE IRON CHELATORS AND PHARMACEUTICAL COMPOSITIONS THEREWITH
JP2006524708A (ja) * 2003-04-25 2006-11-02 インディヴァス ファーマシューティカルズ，インコーポレーテッド 塩化トロスピウムの投与により連続睡眠を促進するための方法
WO2005051371A1 (en) * 2003-11-25 2005-06-09 Technion Research & Development Foundation Ltd. Compositions and methods for treatment of cardiovascular disorders and diseases
US8097608B2 (en) * 2003-11-25 2012-01-17 Technion Research And Development Foundation Ltd. Methods for treatment of cardiovascular disorders and diseases
JP2005232148A (ja) * 2004-02-03 2005-09-02 Technion Research & Development Foundation Ltd 神経保護剤としてプロパルギルアミンの使用
FR2884421B1 (fr) 2005-04-15 2007-08-10 Virbac Sa Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
US8263655B2 (en) * 2005-10-06 2012-09-11 Technion Research And Development Foundation Ltd Methods for treatment of renal failure
RU2513262C2 (ru) * 2009-12-29 2014-04-20 Хилл'С Пет Ньютришн, Инк. Композиции, включающие пируват, для животных-компаньонов и способы их применения
PT2531181T (pt) 2010-02-03 2019-07-17 Pharma Two B Ltd Formulações de libertação prolongada de rasagilina e suas utilizações
CN103860503A (zh) * 2012-12-10 2014-06-18 天津市汉康医药生物技术有限公司 一种治疗帕金森病的缓释药物组合物及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA871155A (en) * 1971-05-18 Chinoin Gyogyszer-Es Vegyeszeti Termekek Gyara Rt Optically active phenyl isopropylamine derivatives having pharmaceutical properties and their preparation
HU187775B (en) * 1982-07-14 1986-02-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu New process for producing propargile-amines of pharmaceutical activity
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
US4880883A (en) * 1987-06-03 1989-11-14 Wisconsin Alumni Research Foundation Biocompatible polyurethanes modified with lower alkyl sulfonate and lower alkyl carboxylate
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5192808A (en) * 1990-08-31 1993-03-09 Deprenyl Animal Health, Inc. Therapeutic effect of L-deprenyl in the management of pituitary-dependent hyperadrenocorticism (cushing's disease)
CA2039194C (en) * 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same

Also Published As

Publication number Publication date
DE69124875D1 (de) 1997-04-10
AU633714B2 (en) 1993-02-04
DK0473252T3 (da) 1997-09-15
EP0732101B1 (en) 1999-06-23
US5276057A (en) 1994-01-04
EP0473252A3 (en) 1992-08-05
DE69124875T2 (de) 1997-06-26
JP2884501B2 (ja) 1999-04-19
NZ238277A (en) 1993-10-26
MX9100067A (es) 1992-04-01
CA2039194C (en) 1997-01-28
EP0473252B1 (en) 1997-03-05
MY124210A (en) 2006-06-30
AU7395791A (en) 1992-03-05
EP0732101A1 (en) 1996-09-18
JPH04230624A (ja) 1992-08-19
GR3022971T3 (en) 1997-06-30
DE69131386T2 (de) 1999-11-25
EP0473252A2 (en) 1992-03-04
ES2135123T3 (es) 1999-10-16
CA2039194A1 (en) 1992-03-01
JPH09328423A (ja) 1997-12-22
JPH09328422A (ja) 1997-12-22
MY110217A (en) 1998-03-31
ES2097790T3 (es) 1997-04-16
ATE149350T1 (de) 1997-03-15
ATE181501T1 (de) 1999-07-15
JP2884500B2 (ja) 1999-04-19
DE69131386D1 (de) 1999-07-29
JP2819072B2 (ja) 1998-10-30
US5387615A (en) 1995-02-07
HK1011611A1 (en) 1999-07-16
DK0732101T3 (da) 1999-11-22
ID19492A (id) 1998-07-16
GR3031263T3 (en) 1999-12-31

Similar Documents

Publication Publication Date Title
BR9103506A (pt) Novos usos de l-deprenil e composicoes para ele
MX9101046A (es) Anticuerpos novedosos para el tratamiento y prevencion de infeccion de animales y el hombre
SE503436C2 (sv) Pyroglutamidderivat
DE3851456D1 (de) Synergetische immunostimulierende Zusammensetzung und ihre Verwendung.
IT8167952A0 (it) Dispositivo di collegamento disinnestabile per guinzagli per animali domestici cinture di sicurezza osimili
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
ES540521A0 (es) Sistema perfeccionado de vivero flotante para la cria de es-pecies acuaticas,en particular moluscos
ES2094240T3 (es) Utilizacion de diol diesteres en los alimentos para perros y gatos.
PT85131A (pt) Dispositivo para disribuicao controlada de substancias pastosas
IT1171125B (it) Composizione per uso orale particolarmente destinata al trattamento terapeutico di animali
MX9201735A (es) Composicion farmaceutica para el tratamiento y profilaxis de inflamacion y dolor en mamiferos.
MX9203784A (es) Composiciones para el tratamiento de osteoporosis en seres humanos.
ES1002871Y (es) Carro-jaula para el transporte de pequenos animales
MX164684B (es) Sustituto de leche para alimentacion animal y procedimiento para preparar el mismo
ES263684Y (es) "jaula de pisos perfeccionada, para la cria y recria en avicultura".
ES285318Y (es) Tapete perfeccionado para el juego del mus
ES1001196Y (es) Dispositivo perfeccionado para la eliminacion de insectos
ES294387Y (es) Herradura de caucho para caballerias
ES280608Y (es) Dispositivo perfeccionado para el cultivo mecanico de la vid
ES1002485Y (es) Criadero termico para ganado
IT219064Z2 (it) Sollevatore manuale di contenitori impiegati per il trasporto di mercio come unita' abitative e simili,perfezionato
ES1018446Y (es) "dispositivo para el agrupado de cubiertos de juguete"
BR6602122U (pt) Ferradura amortecedora e antiderrapante para cavalos

Legal Events

Date Code Title Description
HE Change of address
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal